Covid Map Shows Latest Rates Across U.S. Before Christmas

As families prepare to gather for the holidays, a new COVID-19 map reveals the latest infection rates across the United States.

What’s New

For the week ending December 14, 5.6 percent of tests nationwide came back positive, up from 5 percent the previous week.

Wyoming, Utah, South Dakota, North Dakota, Montana and Colorado, as well as Wisconsin, Ohio, Minnesota, Michigan, Indiana and Illinois had the highest percentage of positive tests, at 7.3 percent in the week ending December 14.

There was a 6.6 percent positivity rate across Texas, Oklahoma, New Mexico, Louisiana and Arkansas, while Nebraska, Missouri and Kansas had a 6.3 percent positivity rate.

The Virgin Islands, Puerto Rico, New York and New Jersey had a 5 percent positivity rate. In all the other states, less than 5 percent of tests came back positive.

Tennessee, South Carolina, North Carolina, Mississippi, Kentucky, Georgia, as well as Florida and Alabama had, had the lowest positivity rate, with just 2.3 percent of tests coming back positive.

Christmas Covid map
CDC map showing regions with highest rates of positive COVID-19 tests for the week ending December 14. In regions highlighted in green, the rate is between 5 and 9.9 percent. In regions highlighted in blue,…


CDC

Nationwide, CDC data shows that across the country, 0.7 percent of visits to the ER were associated with COVID-19 on the week ending 14 December. New Mexico had the highest percentage these, at 2 percent. Kentucky followed with 1.4 percent, while 1.3 percent of ER visits in South Dakota and Indiana were associated with COVID-19. In New Hampshire and Arizona, 1.2 percent of ER visits were associated with the virus. And 1.1 percent of ER visits were associated with COVID-19 in Wisconsin, West Virginia, Maine, Kansas, Illinois and Colorado.

In all the other states, less than 1.1 percent of ER visits were associated with COVID.

There were 254 COVID-19 deaths nationwide during the week ending December 14, down from 335 the week before but up from 179 deaths the week ending November 30.

The CDC monitors COVID-19 levels in wastewater as part of its surveillance strategy to track the spread of the virus in communities. Infected individuals shed the virus in their feces, meaning that monitoring wastewater can reveal increases in infection rates earlier than clinical testing or hospitalizations.

“The wastewater viral activity level indicates whether the amount of virus in the wastewater is minimal, low, moderate, high or very high. The wastewater viral activity levels may indicate the risk of infection in an area,” the CDC said.

Currently, only New Mexico, Kansas and New Hampshire have very high levels of SARS-CoV-2 in its wastewater. Nationwide, the levels of SARS-CoV-2 in wastewater is moderate.

Why It Matters

The world was transformed by the emergence of SARS-CoV-2, the coronavirus that causes COVID-19. Business as usual ground to a halt when the World Health Organization (WHO) declared a pandemic on March 11, 2020, about four months after the virus was first detected in Wuhan, China.

Since the pandemic was affirmed, the WHO reports that around 777 million people have been infected by the virus worldwide. Meanwhile, the illness has an overall worldwide mortality rate of a little less than 1 percent—much higher than common ailments like the flu.

In the United States, at least 103 million COVID-19 cases have been reported since the pandemic began. The Centers for Disease Control and Prevention (CDC) reports that at least 1.21 million people have officially died of the illness in the U.S., although the actual number of deaths could be higher.

COVID-19 rates across the U.S. are expected to grow over the winter holiday period.

What To Know

The CDC recommends that everyone aged 6 months and older should get a COVID-19 vaccine this season, meaning from October 2024 to September 2025.

This is because vaccine protection decreases over time and because the vaccines are updated to give people the best protection against new strains. A meta-analysis of seven COVID-19 studies, published by medical journal Cureus in August 2023, found that people who are unvaccinated are 2.46 times more likely to die of COVID-19 than those who are vaccinated.

The newest COVID-19 strain is called XEC, a subvariant of Omicron that is believed to be more transmissible, but milder than previous strains.

The CDC lists current likely symptoms of COVID-19 as:

  • Fever or chills
  • Cough
  • Shortness of breath or difficulty breathing
  • Sore throat
  • Congestion or runny nose
  • New loss of taste or smell
  • Fatigue
  • Muscle or body aches
  • Headache
  • Nausea or vomiting
  • Diarrhea

Many of these symptoms overlap with other illnesses, such as flu, which is why experts advise taking a test to find out what the illness is. These can be mailed to people’s homes for free.

What People Are Saying

A spokesperson for the CDC previously told Newsweek: “As of December 13, 2024, COVID-19 activity is beginning to increase from low levels in some areas of the nation. Based on CDC modeled estimates of epidemic growth, we predict COVID-19 illness to increase in the coming weeks, as it usually does in the winter.”

Francois Balloux, a professor of computational systems biology at University College London in England, previously told Newsweek: “There is no evidence, and no particular reason to believe, that XEC causes different symptoms than all the other SARS-CoV-2 currently in circulation. XEC is not expected to cause more (or less) severe symptoms than other lineages currently in circulation.”

What Happens Next

The CDC will continue tracking COVID-19 data. A spike in illnesses is expected over the coming weeks. However, this is not unusual in winter time.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Fauci was told by Feb. 2020 that COVID was already ‘adapted’ to humans

U.S. and Chinese government officials knew as early as February 2020 that the emerging novel coronavirus that causes COVID-19 had already been well-adapted to humans – an early signal not only that it would spread efficiently, but also that it may not have emerged at the Wuhan wet market. Recently released chat messages indicate that

Three questions on “The Missed Opportunity for Reform in the Wake of COVID-19”

This conversation is with the authors of the chapter “Everything Is Different but Nothing Is New: The Missed Opportunity for Reform in the Wake of COVID-19” in our new co-edited book, Recentering Learning: Complexity, Resilience, and Adaptability in Higher Education (JHU Press, 2024). The book (in paper and ebook form) is available for order from

What is health equity and how can it help achieve universal health coverage?

    Universal Health Coverage (UHC) means everyone can access healthcare without financial hardship, but progress towards achieving this has stalled. The latest research on achieving UHC also focuses on the need for health equity, which is when everyone can attain their full health and wellbeing potential. This will require a willingness by healthcare leaders

Moderna | History, Innovation, Challenges, & Facts

Moderna uses mRNA technology to combat COVID-19, RSV, cancer, and rare diseases. © Plexi Images/GHI/UCG—Universal Images Group/Getty Images Share price: $38.36 (mkt close, Dec. 18, 2024) Annual revenue: $5.08 bil. Earnings per share (prev. year): $-5.81 Moderna, Inc. is a biotechnology company specializing in messenger RNA (mRNA) medicines and is best known for developing one

American lifespans increased in 2023

Average life expectancy in the U.S. increased by almost a year in 2023, rebounding to a level not reached since the COVID-19 pandemic, according to figures released Thursday by the Centers for Disease Control and Prevention. U.S. average life expectancy was 78.4 years in 2023 ‒ nearly 11 months longer than in 2022 ‒ mostly

New long COVID index highlights five symptom subtypes

RECOVER-Adult study reveals refined thresholds and symptom categorization, advancing research into long COVID’s complexities. Study: 2024 Update of the RECOVER-Adult Long COVID Research Index. Image Credit: Branislav Nenin / Shutterstock.com The 2023 research index for adults with post-coronavirus disease 2019 (COVID-19) condition or long COVID has been updated using additional participant data from the Researching COVID

0
Would love your thoughts, please comment.x
()
x